arXiv subjects

Berit Lange

Publications and source records attributed to Berit Lange.

4 recordsLinked to original sources

arXiv2026

A full software stack for epidemic disease management: Unlocking the joint potential of software technology and supercomputing

Infectious diseases remain a major threat to human societies. During the recent COVID-19 pandemic, mathematical modeling and extensive computer simulations proved highly effective in supporting public health experts and decision makers. Despite these advances, the full potential of modern modeling approaches and digital technologies has not yet been realized. Many critical tasks -- including expert consultations, model execution, scenario analyses, report preparation, and result communication -- still relied heavily on manual, human-driven processes with each manual interaction introducing avoidable delays and limiting responsiveness during rapidly evolving outbreaks. Pandemic preparedness should opt for automated workflows and seamlessly integrated software modules that can improve pandemic mitigation capabilities by substantially reducing response times. For this step, we require robust and flexible computational infrastructure capable of supporting heterogeneous hardware and continuously evolving infectious-disease models. In addition, data sources need to be dynamically integrated. Managing such demands needs infrastructure that supports automated high-performance computing (HPC) workflows. Beyond computational performance, software infrastructure must ensure secure user and data management to comply with data-protection regulations and provide clear, transparent presentation of results to both decision makers and the public. Meeting the aforementioned challenges requires tight integration of state-of-the-art scientific software with modern, scalable infrastructure that can leverage supercomputing resources when necessary. For rapid deployment in future epidemic or pandemic scenarios, adherence to the FAIR principles for research software is critical to ensure reusability and sustainability.

cs.CE↗

arXiv2025

Can synthetic data reproduce real-world findings in epidemiology? A replication study using adversarial random forests

Synthetic data holds substantial potential to address practical challenges in epidemiology due to restricted data access and privacy concerns. However, many current methods suffer from limited quality, high computational demands, and complexity for non-experts. Furthermore, common evaluation strategies for synthetic data often fail to directly reflect statistical utility and measure privacy risks sufficiently. Against this background, a critical underexplored question is whether synthetic data can reliably reproduce key findings from epidemiological research while preserving privacy. We propose adversarial random forests (ARF) as an efficient and convenient method for synthesizing tabular epidemiological data. To evaluate its performance, we replicated statistical analyses from six epidemiological publications covering blood pressure, anthropometry, myocardial infarction, accelerometry, loneliness, and diabetes, from the German National Cohort (NAKO Gesundheitsstudie), the Bremen STEMI Registry U45 Study, and the Guelph Family Health Study. We further assessed how dataset dimensionality and variable complexity affect the quality of synthetic data, and contextualized ARF's performance by comparison with commonly used tabular data synthesizers in terms of utility, privacy, generalisation, and runtime. Across all replicated studies, results on ARF-generated synthetic data consistently aligned with original findings. Even for datasets with relatively low sample size-to-dimensionality ratios, replication outcomes closely matched the original results across descriptive and inferential analyses. Reduced dimensionality and variable complexity further enhanced synthesis quality. ARF demonstrated favourable performance regarding utility, privacy preservation, and generalisation relative to other synthesizers and superior computational efficiency.

q-bio.QM↗

arXiv2021

Nachhaltige Strategien gegen die COVID-19-Pandemie in Deutschland im Winter 2021/2022

In this position paper, a large group of interdisciplinary experts outlines response strategies against the spread of SARS-CoV-2 in the winter of 2021/2022 in Germany. We review the current state of the COVID-19 pandemic, from incidence and vaccination efficacy to hospital capacity. Building on this situation assessment, we illustrate various possible scenarios for the winter, and detail the mechanisms and effectiveness of the non-pharmaceutical interventions, vaccination, and booster. With this assessment, we want to provide orientation for decision makers about the progress and mitigation of COVID-19.

q-bio.OT↗

arXiv2020

Assessing Excess Mortality in Times of Pandemics Based on Principal Component Analysis of Weekly Mortality Data -- The Case of COVID-19

The current outbreak of COVID-19 has called renewed attention to the need for sound statistical analysis for monitoring mortality patterns and trends over time. Excess mortality has been suggested as the most appropriate indicator to measure the overall burden of the pandemic on mortality. As such, excess mortality has received considerable interest during the first months of the COVID-19 pandemic. Previous approaches to estimate excess mortality are somewhat limited, as they do not include sufficiently long-term trends, correlations among different demographic and geographic groups, and the autocorrelations in the mortality time series. This might lead to biased estimates of excess mortality, as random mortality fluctuations may be misinterpreted as excess mortality. We present a blend of classical epidemiological approaches to estimating excess mortality during extraordinary events with an established demographic approach in mortality forecasting, namely a Lee-Carter type model, which covers the named limitations and draws a more realistic picture of the excess mortality. We illustrate our approach using weekly age- and sex-specific mortality data for 19 countries and the current COVID-19 pandemic as a case study. Our proposed model provides a general framework that can be applied to future pandemics as well as to monitor excess mortality from specific causes of deaths.

stat.AP↗